| Serina Therapeutics to Present at the 38th Annual Roth Conference |
Globe Newswire |
03/24 |
06:00 |
| GEN Restaurant Group to Hold Fourth Quarter 2025 Conference Call on Tuesday, March 31, 2026 at 5:00 p.m. ET |
Globe Newswire |
03/24 |
06:00 |
| iDEL Therapeutics Appoints Claudia Ulbrich as Chair of its Board of Directors |
Globe Newswire |
03/24 |
06:00 |
| Nature Translational Psychiatry Study Reveals Distinct Functional Neuronal Signatures in Patient-Derived Brain Organoids with Itay&Beyond’s Neurotech Platform |
Globe Newswire |
03/24 |
05:00 |
| DeepBrain AI Launches Interactive AI Video Agents for Enterprise |
Globe Newswire |
03/24 |
04:50 |
| Smithfield Foods Reports Record Fiscal 2025 Results |
Globe Newswire |
03/24 |
04:30 |
| Philips remains No. 1 in Medtech at European Patent Office and the largest Dutch patent applicant |
Globe Newswire |
03/24 |
04:30 |
| Hesai Group Reports Fourth Quarter and Full Year 2025 Unaudited Financial Results |
Globe Newswire |
03/24 |
04:30 |
| Netflix’s Chief Marketing Officer, Marian Lee, Takes Center Stage at Licensing Expo 2026 for an Opening Keynote on the Netflix Effect and Fandom |
Globe Newswire |
03/24 |
04:00 |
| Kandi Technologies Unveils Brand Upgrade to Highlight Intelligent Transformation and Diversified Growth Strategy |
Globe Newswire |
03/24 |
04:00 |
| Genenta, evolving into Saentra Forge, continues to evaluate strategic options for its original biotechnology platform derived from the research of Professor Luigi Naldini |
Globe Newswire |
03/24 |
03:26 |
| Progress on share buyback programme |
Globe Newswire |
03/24 |
03:00 |
| Press release: Availability of the Q1 2026 aide-mémoire |
Globe Newswire |
03/24 |
02:30 |
| Technip Energies convenes its 2026 Annual General Meeting |
Globe Newswire |
03/24 |
02:30 |
| SBM Offshore awarded FEED contracts for the Longtail project in Guyana |
Globe Newswire |
03/24 |
02:30 |
| CGTN: How Xiongan is evolving into a model for high-quality urban growth |
Globe Newswire |
03/24 |
02:21 |
| Press Release: Sanofi and Regeneron’s Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid |
Globe Newswire |
03/24 |
02:00 |
| Pharming Group announces approval of Joenja® (leniolisib) in Japan for the treatment of APDS in patients aged 4 years and older |
Globe Newswire |
03/24 |
02:00 |
| Dupixent® (dupilumab) Approved in Japan as the First Targeted Medicine to Treat Adults with Bullous Pemphigoid (BP) |
Globe Newswire |
03/24 |
02:00 |
| Still the 1. One perfect women's March Madness bracket going into Sweet 16 |
AP Online |
03/24 |
01:31 |
| Here's what to know as the scope of damage from Hawaii's floods becomes clearer |
AP Online |
03/24 |
01:29 |
| Phonak AI-Powered Hearing Aids Recognized with 2026 Artificial Intelligence Excellence Awards |
Globe Newswire |
03/24 |
01:05 |
| anynines advances Klutch to power a9s Hub for Kubernetes data service orchestration across on-premises and AWS environments |
Globe Newswire |
03/24 |
01:00 |
| EU and Australia sign free trade pact and announce a new defense partnership |
AP Online |
03/24 |
00:28 |
| Victor Wembanyama wants the MVP award, and wants to leave no doubt by season's end |
AP Online |
03/24 |
00:12 |
